Clinical Trial Update: " Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD " [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating safety and efficacy of empagliflozin and sacubitril/valsartan for heart failure with reduced ejection fraction in adults with congenit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Heart Failure
• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Empagliflozin (empagliflozin)
• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: Instituto Nacional de Cardiologia Ignacio Chavez | Conditions: Congenital Heart Disease, Heart Failure | Phase 2, Phase 3 | Status: UNKNOWN